Recent posts

TypePostAuthorRepliesLast updated
Blog entryDetailed Presentation of New Casting Text to be discussed at SCCR34 Manon Ress03 weeks 5 days ago
Blog entrySCCR34: Atmospherics of WIPO negotiations on a broadcasting treaty thiru03 weeks 6 days ago
Blog entry WIPO SCCR 34 May 1, 2017 Day 1: Agenda and Election of New Chair and Vice Chairs Manon Ress03 weeks 6 days ago
Blog entryGeneral Statements by Regional Groups regarding the Agenda of SCCR 34 Manon Ress03 weeks 6 days ago
Book pageWIPO SCCR 34 thiru03 weeks 6 days ago
PageWIPO SCCR 33 James Love03 weeks 6 days ago
Blog entryHow Sanofi Prices Its MS Drug Aubagio (Teriflunomide) in the U.S. and Five Reference Countries Zack Struver04 weeks 1 day ago
PageJobs at KEI James Love04 weeks 1 day ago
Blog entryU.S. Army Rejects Pricing Concerns in Grant of Exclusive Patent License to Sanofi on Zika Vaccine KEI Staff04 weeks 3 days ago
Blog entryFeb 24, 2017 - U.S. History, Experiences, and Prospects of Compulsory Licensing of Medical Patents Claire Cassedy05 weeks 2 days ago
Blog entryKEI, UACT Request that Trump Administration Reevaluate Xtandi Petition Andrew Goldman05 weeks 2 days ago
PageDecember 2, 2016 Delinkage Meeting: Powerpoints and Video Recording KEI Staff05 weeks 6 days ago
PageXtandi March-in Request, links to news stories, blogs Zack Struver07 weeks 4 days ago
Blog entryKEI Statement on House Letter to President Trump on the Protection of Taxpayers’ Rights in Federally-Funded Inventions Zack Struver07 weeks 4 days ago
Blog entryDemocrats in House and Senate introduce new drug pricing bill James Love08 weeks 3 days ago
Blog entryKEI statement: 21st meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines thiru08 weeks 6 days ago
Blog entryDr. Elias Zerhouni defends Sanofi/Army proposed license on Zika patents, and KEI responds James Love09 weeks 3 days ago
Blog entry14 March 2017 - Senate Finance Committee grills Robert Lighthizer (USTR nominee) on trade and IPR policies thiru09 weeks 4 days ago
Blog entryMaryland House of Delegates passes bill on prescription drug price gouging by vote of 137 to 4 James Love09 weeks 4 days ago
Blog entryLeaked: Three documents from RCEP negotiations James Love09 weeks 4 days ago
Blog entryLeaked document: March 15, 2017 Note by Switzerland on India EFTA TEPA IP Chapter James Love09 weeks 4 days ago
Blog entryPatients, Members of Congress Ask Chilean Government to Issue Compulsory Licenses on Prostate Cancer and HCV Drug Patents Zack Struver09 weeks 5 days ago
Blog entryKEI Testifies in Maryland on Drug R&D Cost Transparency Bill (HB666/SB437) Zack Struver010 weeks 2 days ago
PageResearch and Development Cost Transparency Legislation Zack Struver010 weeks 2 days ago
Blog entryHHS Office of Inspector General Declines to Investigate Failure to Disclose Federal Funding in Ionis Pharmaceuticals' Spinraza Zack Struver010 weeks 2 days ago